PT1727550E - Composição farmacêutica que compreende um derivado de benzodiazepina e um inibidor da proteína de fusão do vsr - Google Patents
Composição farmacêutica que compreende um derivado de benzodiazepina e um inibidor da proteína de fusão do vsr Download PDFInfo
- Publication number
- PT1727550E PT1727550E PT05718061T PT05718061T PT1727550E PT 1727550 E PT1727550 E PT 1727550E PT 05718061 T PT05718061 T PT 05718061T PT 05718061 T PT05718061 T PT 05718061T PT 1727550 E PT1727550 E PT 1727550E
- Authority
- PT
- Portugal
- Prior art keywords
- inhibitor
- pharmaceutical composition
- fusion protein
- benzodiazepine derivative
- rsv fusion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0406282.4A GB0406282D0 (en) | 2004-03-19 | 2004-03-19 | Therapeutic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1727550E true PT1727550E (pt) | 2009-08-28 |
Family
ID=32118068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT05718061T PT1727550E (pt) | 2004-03-19 | 2005-03-18 | Composição farmacêutica que compreende um derivado de benzodiazepina e um inibidor da proteína de fusão do vsr |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8853204B2 (pt) |
| EP (1) | EP1727550B1 (pt) |
| JP (1) | JP4940128B2 (pt) |
| KR (2) | KR101292431B1 (pt) |
| CN (1) | CN1933842A (pt) |
| AT (1) | ATE437643T1 (pt) |
| AU (2) | AU2005224157B2 (pt) |
| BR (1) | BRPI0507654A (pt) |
| CA (1) | CA2558112C (pt) |
| CY (1) | CY1109523T1 (pt) |
| DE (1) | DE602005015686D1 (pt) |
| DK (1) | DK1727550T3 (pt) |
| ES (1) | ES2327757T3 (pt) |
| GB (1) | GB0406282D0 (pt) |
| HK (1) | HK1098372A1 (pt) |
| PL (1) | PL1727550T3 (pt) |
| PT (1) | PT1727550E (pt) |
| RU (1) | RU2388476C2 (pt) |
| WO (1) | WO2005089769A1 (pt) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0406279D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| US20100056500A1 (en) * | 2006-11-21 | 2010-03-04 | Thitiwan Buranachokaisan | Stable Parenteral Formulation |
| GB201506448D0 (en) | 2015-04-16 | 2015-06-03 | Univ Durham | An antimicrobial compound |
| LT3324977T (lt) | 2015-07-22 | 2022-10-25 | Enanta Pharmaceuticals, Inc. | Benzodiazepino dariniai kaip rsv inhibitoriai |
| EP3402799B1 (en) | 2016-01-15 | 2022-05-04 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as rsv inhibitors |
| GB201613942D0 (en) * | 2016-08-15 | 2016-09-28 | Univ Of Durham The | An antimicrobial compound |
| US10398706B2 (en) | 2017-01-06 | 2019-09-03 | Enanta Pharmaceuticals, Inc. | Heteroaryldiazepine derivatives as RSV inhibitors |
| AU2018221820B2 (en) | 2017-02-16 | 2023-11-02 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of benzodiazepine derivatives |
| WO2018226801A1 (en) | 2017-06-07 | 2018-12-13 | Enanta Pharmaceuticals, Inc. | Aryldiazepine derivatives as rsv inhibitors |
| WO2019006295A1 (en) | 2017-06-30 | 2019-01-03 | Enanta Pharmaceuticals, Inc. | HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS |
| WO2019006291A1 (en) | 2017-06-30 | 2019-01-03 | Enanta Pharmaceuticals, Inc. | HETEROCYCLIC COMPOUNDS AS RSV INHIBITORS |
| US10881666B2 (en) * | 2017-09-29 | 2021-01-05 | Enanta Pharmaceuticals, Inc. | Combination pharmaceutical agents as RSV inhibitors |
| WO2019094920A1 (en) * | 2017-11-13 | 2019-05-16 | Enanta Pharmaceuticals, Inc. | Azepin-2-one derivatives as rsv inhibitors |
| IL274534B (en) * | 2017-11-13 | 2022-07-01 | Enanta Pharm Inc | Processes for the separation of 2-one benzodiazepines and 2-one benzodiazepine derivatives |
| US10975094B2 (en) | 2018-04-11 | 2021-04-13 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as RSV inhibitors |
| AU2020240024A1 (en) | 2019-03-18 | 2021-10-14 | Enanta Pharmaceuticals, Inc. | Benzodiazepine derivatives as RSV inhibitors |
| WO2020210246A1 (en) | 2019-04-09 | 2020-10-15 | Enanta Pharmaceuticals, Inc, | Heterocyclic compounds as rsv inhibitors |
| GB201911944D0 (en) | 2019-08-20 | 2019-10-02 | Reviral Ltd | Pharmaceutical compounds |
| US11505558B1 (en) | 2019-10-04 | 2022-11-22 | Enanta Pharmaceuticals, Inc. | Antiviral heterocyclic compounds |
| CA3153297A1 (en) | 2019-10-04 | 2021-04-08 | Adam SZYMANIAK | Antiviral heterocyclic compounds |
| GB201915273D0 (en) * | 2019-10-22 | 2019-12-04 | Reviral Ltd | Pharmaceutical compounds |
| UY39032A (es) | 2020-01-24 | 2021-07-30 | Enanta Pharm Inc | Compuestos heterocíclicos como agentes antivirales |
| US11534439B2 (en) | 2020-07-07 | 2022-12-27 | Enanta Pharmaceuticals, Inc. | Dihydroquinoxaline and dihydropyridopyrazine derivatives as RSV inhibitors |
| WO2022086840A1 (en) | 2020-10-19 | 2022-04-28 | Enanta Pharmaceuticals, Inc. | Heterocyclic compounds as anti-viral agents |
| MX2023009961A (es) | 2021-02-26 | 2023-09-05 | Enanta Pharm Inc | Compuestos heterociclicos antivirales. |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4324794A (en) * | 1980-08-26 | 1982-04-13 | Research Triangle Institute | Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds |
| EP0491218A1 (en) * | 1990-12-17 | 1992-06-24 | F. Hoffmann-La Roche Ag | Benzodiazepinones |
| PL336233A1 (en) * | 1997-04-07 | 2000-06-19 | Axys Pharm Inc | Compounds and agents for treating diseases associated with serinic protease activity, in particular tryptase activity |
| US6489338B2 (en) * | 2000-06-13 | 2002-12-03 | Bristol-Myers Squibb Company | Imidazopyridine and imidazopyrimidine antiviral agents |
| US6506738B1 (en) * | 2000-09-27 | 2003-01-14 | Bristol-Myers Squibb Company | Benzimidazolone antiviral agents |
| US6919331B2 (en) * | 2001-12-10 | 2005-07-19 | Bristol-Myers Squibb Company | Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents |
| EP1461036A4 (en) * | 2001-12-10 | 2005-11-16 | Bristol Myers Squibb Co | BIS HYDROCHLORIDE SALT MONOHYDRATE OF A SYNCYTIAL RESPIRATORY VIRUS FUSION INHIBITOR (RSV) |
| JP2004107494A (ja) * | 2002-09-18 | 2004-04-08 | National Institute For Materials Science | 熱可塑性層状アルキルシロキサンとその製造方法 |
| CA2499322C (en) * | 2002-09-20 | 2012-04-24 | Arrow Therapeutics Limited | Benzodiapine derivatives and pharmaceutical compositions containing them |
| GB0406279D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
-
2004
- 2004-03-19 GB GBGB0406282.4A patent/GB0406282D0/en not_active Ceased
-
2005
- 2005-03-18 WO PCT/GB2005/001018 patent/WO2005089769A1/en active Application Filing
- 2005-03-18 PT PT05718061T patent/PT1727550E/pt unknown
- 2005-03-18 EP EP05718061A patent/EP1727550B1/en not_active Not-in-force
- 2005-03-18 PL PL05718061T patent/PL1727550T3/pl unknown
- 2005-03-18 KR KR1020067021650A patent/KR101292431B1/ko not_active IP Right Cessation
- 2005-03-18 DK DK05718061T patent/DK1727550T3/da active
- 2005-03-18 US US10/593,666 patent/US8853204B2/en not_active Expired - Fee Related
- 2005-03-18 KR KR1020137005341A patent/KR20130042593A/ko not_active Application Discontinuation
- 2005-03-18 AU AU2005224157A patent/AU2005224157B2/en not_active Ceased
- 2005-03-18 JP JP2007503410A patent/JP4940128B2/ja not_active Expired - Fee Related
- 2005-03-18 RU RU2006136880/15A patent/RU2388476C2/ru not_active IP Right Cessation
- 2005-03-18 CN CNA2005800089279A patent/CN1933842A/zh active Pending
- 2005-03-18 AT AT05718061T patent/ATE437643T1/de active
- 2005-03-18 DE DE602005015686T patent/DE602005015686D1/de active Active
- 2005-03-18 BR BRPI0507654-4A patent/BRPI0507654A/pt not_active IP Right Cessation
- 2005-03-18 ES ES05718061T patent/ES2327757T3/es active Active
- 2005-03-18 CA CA2558112A patent/CA2558112C/en not_active Expired - Fee Related
-
2007
- 2007-05-08 HK HK07104918.4A patent/HK1098372A1/xx not_active IP Right Cessation
-
2009
- 2009-08-26 AU AU2009212826A patent/AU2009212826A1/en not_active Abandoned
- 2009-10-26 CY CY20091101108T patent/CY1109523T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1098372A1 (en) | 2007-07-20 |
| US20070142403A1 (en) | 2007-06-21 |
| RU2388476C2 (ru) | 2010-05-10 |
| DK1727550T3 (da) | 2009-10-19 |
| WO2005089769A1 (en) | 2005-09-29 |
| JP2007529489A (ja) | 2007-10-25 |
| CA2558112C (en) | 2014-07-29 |
| AU2005224157B2 (en) | 2009-05-28 |
| GB0406282D0 (en) | 2004-04-21 |
| EP1727550A1 (en) | 2006-12-06 |
| ATE437643T1 (de) | 2009-08-15 |
| PL1727550T3 (pl) | 2010-01-29 |
| CA2558112A1 (en) | 2005-09-29 |
| CY1109523T1 (el) | 2014-08-13 |
| ES2327757T3 (es) | 2009-11-03 |
| RU2006136880A (ru) | 2008-04-27 |
| EP1727550B1 (en) | 2009-07-29 |
| AU2009212826A1 (en) | 2009-09-17 |
| BRPI0507654A (pt) | 2007-07-10 |
| KR101292431B1 (ko) | 2013-07-31 |
| DE602005015686D1 (de) | 2009-09-10 |
| JP4940128B2 (ja) | 2012-05-30 |
| KR20130042593A (ko) | 2013-04-26 |
| AU2005224157A1 (en) | 2005-09-29 |
| US8853204B2 (en) | 2014-10-07 |
| KR20070009629A (ko) | 2007-01-18 |
| CN1933842A (zh) | 2007-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1727551T3 (pl) | Kompozycja farmaceutyczna zawierająca pochodną benzodiazepiny i inhibitor fuzji białek RSV | |
| HK1098372A1 (en) | Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein | |
| AU2003264038A1 (en) | Combination pharmaceutical agents as inhibitors of hcv replication | |
| WO2006128184A3 (en) | Pyrimidine or triazine fused bicyclic metalloprotease inhibitors | |
| WO2007139856A3 (en) | Heterobicyclic metalloprotease inhibitors | |
| MXPA05002871A (es) | Derivados de benzodiazaepina y composiciones farmaceuticas que los contienen. | |
| UA89220C2 (ru) | Способ лечения вич/спида путем приема без пищи или в условиях голодания твердого фармацевтического дозированного состава ингибитора вич-протеазы | |
| MY143407A (en) | Indazole derivatives as inhibitors of hormone sensitive lipase | |
| MXPA04003668A (es) | Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos. | |
| AU2003244632A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| PT1261586E (pt) | Inibidores da dipeptidil peptidase iv à base de pirrolidina condensada com ciclopropilo, processos para a sua preparação e sua utilização | |
| CA2504735A1 (en) | Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes | |
| WO2000055124A3 (en) | Novel compounds and compositions as protease inhibitors | |
| AU2002338806A1 (en) | Pharmaceutical combinations of pde-v inhibitors and other agents | |
| AU2003244649A1 (en) | Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them | |
| IL179206A0 (en) | Pyrrolylpyrimidine derivatives and pharmaceutical compositions containing the same | |
| MXPA05010521A (es) | Inhibidores de cinasa de amida de bifenilcarboxilica p38. | |
| AU2001230395A1 (en) | Use of cox-2 inhibitors as gastroprokinetics | |
| AU2003300692A1 (en) | Stable formulations of ace inhibitors and methods for preparation thereof | |
| AU2003201071A1 (en) | Stable pharmaceutical compositions comprising ace inhibitor(s) | |
| WO2004052236A3 (en) | Methods and compositions for treatment of otitis media | |
| MXPA03010054A (es) | Composiciones que comprenden lopinavir y metodos para aumentar la biodisponibilidad de agentes farmaceuticos. | |
| WO2001056555A3 (en) | Use of cox-2 inhibitors for the treatment of constipation | |
| AU2003227186A1 (en) | Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient | |
| AP2203A (en) | Peptide derivative fusion inhibitors of HIV infection. |